Canaccord Genuity Group Cuts Bioceres Crop Solutions (NASDAQ:BIOX) Price Target to $6.50

Bioceres Crop Solutions (NASDAQ:BIOX) had its price target reduced by Canaccord Genuity Group from $7.00 to $6.50 in a research report released on Thursday morning,Benzinga reports. They currently have a buy rating on the stock.

A number of other research firms also recently weighed in on BIOX. Oppenheimer decreased their price objective on Bioceres Crop Solutions from $13.00 to $12.00 and set an “outperform” rating on the stock in a report on Tuesday, January 28th. Lake Street Capital decreased their price objective on Bioceres Crop Solutions from $13.00 to $8.00 and set a “buy” rating on the stock in a report on Friday, February 7th. Four equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, Bioceres Crop Solutions currently has an average rating of “Buy” and an average price target of $9.88.

Bioceres Crop Solutions Stock Up 4.6 %

NASDAQ BIOX opened at $4.96 on Thursday. The company has a current ratio of 1.27, a quick ratio of 0.87 and a debt-to-equity ratio of 0.37. The stock’s 50 day moving average is $6.46 and its two-hundred day moving average is $7.62. The company has a market capitalization of $311.04 million, a price-to-earnings ratio of 248.12 and a beta of 0.57. Bioceres Crop Solutions has a 1-year low of $4.42 and a 1-year high of $13.64.

Institutional Inflows and Outflows

A number of institutional investors have recently modified their holdings of the company. Fourth Sail Capital LP raised its stake in shares of Bioceres Crop Solutions by 16.6% in the fourth quarter. Fourth Sail Capital LP now owns 3,698,961 shares of the company’s stock valued at $22,490,000 after acquiring an additional 527,859 shares during the last quarter. Long Focus Capital Management LLC raised its position in Bioceres Crop Solutions by 130.7% in the 4th quarter. Long Focus Capital Management LLC now owns 744,748 shares of the company’s stock worth $4,528,000 after purchasing an additional 421,931 shares during the last quarter. Ballast Asset Management LP raised its position in Bioceres Crop Solutions by 23.5% in the 4th quarter. Ballast Asset Management LP now owns 431,887 shares of the company’s stock worth $2,620,000 after purchasing an additional 82,187 shares during the last quarter. JPMorgan Chase & Co. raised its position in Bioceres Crop Solutions by 17.0% in the 4th quarter. JPMorgan Chase & Co. now owns 105,301 shares of the company’s stock worth $640,000 after purchasing an additional 15,328 shares during the last quarter. Finally, Stifel Financial Corp raised its position in Bioceres Crop Solutions by 51.9% in the 4th quarter. Stifel Financial Corp now owns 61,958 shares of the company’s stock worth $377,000 after purchasing an additional 21,168 shares during the last quarter. Institutional investors own 17.68% of the company’s stock.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.